Clinical Trials Browser

Phase 1 × Lymphoma, T-Cell × pegylated granulocyte colony-stimulating factor × Clear all

NCT07278856 2025-12-12

Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas

Phase 1 Not yet recruiting

Lymphoma, T-Cell